Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Novel allergen-independent imm...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Novel allergen-independent immunotherapy: positive data from a phase Ila pilot study with CpG contained in virus-like particles
Bibliographic Details
Main Authors:
Bull, C
,
Muller, P
,
Renner, W
,
Bachmann, M
,
Kundig, T
,
Senti, G
Format:
Journal article
Published:
2007
Holdings
Description
Similar Items
Staff View
Similar Items
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
by: Klimek, L, et al.
Published: (2014)
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
by: Senti, G, et al.
Published: (2009)
Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?
by: Kündig, T, et al.
Published: (2010)
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
by: Guillem Montamat, et al.
Published: (2021-02-01)
A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel allergen-independent immunotherapy in patients suffering from grass pollen allergy
by: Senti, G, et al.
Published: (2007)